Skip to main content
. 2014 Jun 12;63(9):939–946. doi: 10.1007/s00262-014-1566-3

Fig. 2.

Fig. 2

Progression-free survival and overall survival. Kaplan–Meier analysis of overall survival after initiation of adoptive immunotherapy using ex vivo-expanded cytokine-induced killer cells. The median progression-free survival was 11.4 weeks, and the median overall survival was 26.6 weeks